Literature DB >> 8406492

Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization.

E A Lindsay1, S Halford, R Wadey, P J Scambler, A Baldini.   

Abstract

DiGeorge syndrome (DGS) is a developmental defect characterized by cardiac defects, facial dysmorphism, and mental retardation. Several studies have described a critical region for DGS at 22q11, within which the majority of DGS patients have deletions. We have isolated nine cosmid and three YAC clones using previously described and newly isolated probes that have been shown to be deleted in many DGS patients. Using fluorescence in situ hybridization and digital imaging, we have mapped and ordered these clones relative to the breakpoints of two balanced translocations at 22q11 (one in a DGS patient and one in the unaffected parent of a DGS child). Our data indicate that the breakpoint in the unaffected individual distally limits the DGS critical region (defined as the smallest region of overlap), while proximally the region is limited by repeat-rich DNA. The critical region includes the balanced translocation breakpoint of the DGS patient that presumably disrupts the gene causing this syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406492     DOI: 10.1006/geno.1993.1339

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  23 in total

1.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome.

Authors:  H F Sutherland; R Wadey; J M McKie; C Taylor; U Atif; K A Johnstone; S Halford; U J Kim; J Goodship; A Baldini; P J Scambler
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Goosecoid-like sequences and the smallest region of deletion overlap in DiGeorge and velocardiofacial syndromes.

Authors:  A Pragliola; V Jurecic; C K Chau; N Philip; A Baldini
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

4.  Cloning and mapping of murine Dgcr2 and its homology to the Sez-12 seizure-related protein.

Authors:  C Taylor; R Wadey; H O'Donnell; C Roberts; M G Mattei; W L Kimber; A Wynshaw-Boris; P J Scambler
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

5.  Two functional copies of the DGCR6 gene are present on human chromosome 22q11 due to a duplication of an ancestral locus.

Authors:  L Edelmann; P Stankiewicz; E Spiteri; R K Pandita; L Shaffer; J R Lupski; B E Morrow; J Lupski
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

6.  Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders.

Authors:  C Carlson; D Papolos; R K Pandita; G L Faedda; S Veit; R Goldberg; R Shprintzen; R Kucherlapati; B Morrow
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome.

Authors:  L Edelmann; R K Pandita; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

8.  Schizophrenia and chromosomal deletions within 22q11.2.

Authors:  E A Lindsay; M A Morris; A Gos; G Nestadt; P S Wolyniec; V K Lasseter; R Shprintzen; S E Antonarakis; A Baldini; A E Pulver
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

9.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.

Authors:  M Karayiorgou; M A Morris; B Morrow; R J Shprintzen; R Goldberg; J Borrow; A Gos; G Nestadt; P S Wolyniec; V K Lasseter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 10.  A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review.

Authors:  Luis Fernández; Julián Nevado; Fernando Santos; Damià Heine-Suñer; Victor Martinez-Glez; Sixto García-Miñaur; Rebeca Palomo; Alicia Delicado; Isidora López Pajares; María Palomares; Luis García-Guereta; Eva Valverde; Federico Hawkins; Pablo Lapunzina
Journal:  BMC Med Genet       Date:  2009-06-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.